Giulio Riboldazzi

2.5k total citations
35 papers, 1.5k citations indexed

About

Giulio Riboldazzi is a scholar working on Neurology, Cellular and Molecular Neuroscience and Psychiatry and Mental health. According to data from OpenAlex, Giulio Riboldazzi has authored 35 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Neurology, 7 papers in Cellular and Molecular Neuroscience and 7 papers in Psychiatry and Mental health. Recurrent topics in Giulio Riboldazzi's work include Parkinson's Disease Mechanisms and Treatments (33 papers), Neurological disorders and treatments (8 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Giulio Riboldazzi is often cited by papers focused on Parkinson's Disease Mechanisms and Treatments (33 papers), Neurological disorders and treatments (8 papers) and Botulinum Toxin and Related Neurological Disorders (6 papers). Giulio Riboldazzi collaborates with scholars based in Italy, United States and United Kingdom. Giulio Riboldazzi's co-authors include Cristoforo Comi, E. Martignoni, Daniela Calandrella, Marco Cosentino, Giuseppe Frazzitta, Roberto Maestri, Roberta Zangaglia, Claudio Pacchetti, Franca Marino and M. Mauri and has published in prestigious journals such as Neurology, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Giulio Riboldazzi

35 papers receiving 1.4k citations

Peers

Giulio Riboldazzi
Giulio Riboldazzi
Citations per year, relative to Giulio Riboldazzi Giulio Riboldazzi (= 1×) peers Henrique Ballalai Ferraz

Countries citing papers authored by Giulio Riboldazzi

Since Specialization
Citations

This map shows the geographic impact of Giulio Riboldazzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giulio Riboldazzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giulio Riboldazzi more than expected).

Fields of papers citing papers by Giulio Riboldazzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giulio Riboldazzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giulio Riboldazzi. The network helps show where Giulio Riboldazzi may publish in the future.

Co-authorship network of co-authors of Giulio Riboldazzi

This figure shows the co-authorship network connecting the top 25 collaborators of Giulio Riboldazzi. A scholar is included among the top collaborators of Giulio Riboldazzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giulio Riboldazzi. Giulio Riboldazzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Albanese, Alberto, Alessio Di Fonzo, V. Fetoni, et al.. (2020). Design and Operation of the Lombardy Parkinson's Disease Network. Frontiers in Neurology. 11. 573–573. 2 indexed citations
2.
Riboldazzi, Giulio, et al.. (2020). Effectiveness of expiratory flow acceleration in patients with Parkinson's disease and swallowing deficiency: A preliminary study. Clinical Neurology and Neurosurgery. 199. 106249–106249. 3 indexed citations
3.
Agliardi, Cristina, Franca Rosa Guerini, Milena Zanzottera, et al.. (2018). SNAP25 Gene Polymorphisms Protect Against Parkinson’s Disease and Modulate Disease Severity in Patients. Molecular Neurobiology. 56(6). 4455–4463. 11 indexed citations
4.
Bianchi, Maria Laura Ester, Giulio Riboldazzi, M. Mauri, & Maurizio Versino. (2018). Efficacy of safinamide on non-motor symptoms in a cohort of patients affected by idiopathic Parkinson’s disease. Neurological Sciences. 40(2). 275–279. 35 indexed citations
5.
Kuštrimović, Nataša, Cristoforo Comi, Luca Magistrelli, et al.. (2018). Parkinson’s disease patients have a complex phenotypic and functional Th1 bias: cross-sectional studies of CD4+ Th1/Th2/T17 and Treg in drug-naïve and drug-treated patients. Journal of Neuroinflammation. 15(1). 205–205. 216 indexed citations
6.
Ferrazzoli, Davide, Paola Ortelli, Giulio Riboldazzi, Roberto Maestri, & Giuseppe Frazzitta. (2018). Effectiveness of Rotigotine plus intensive and goal-based rehabilitation versus Rotigotine alone in “de-novo” Parkinsonian subjects: a randomized controlled trial with 18-month follow-up. Journal of Neurology. 265(4). 906–916. 8 indexed citations
7.
Ferrari, Marco, Cristoforo Comi, Franca Marino, et al.. (2016). Polymorphisms of dopamine receptor genes and risk of visual hallucinations in Parkinson’s patients. European Journal of Clinical Pharmacology. 72(11). 1335–1341. 15 indexed citations
8.
Kuštrimović, Nataša, Emanuela Rasini, Massimiliano Legnaro, et al.. (2016). Dopaminergic Receptors on CD4+ T Naive and Memory Lymphocytes Correlate with Motor Impairment in Patients with Parkinson’s Disease. Scientific Reports. 6(1). 33738–33738. 85 indexed citations
9.
Frazzitta, Giuseppe, Roberto Maestri, Davide Ferrazzoli, et al.. (2015). Multidisciplinary intensive rehabilitation treatment improves sleep quality in Parkinson’s disease. PubMed. 2(1). 11–11. 46 indexed citations
10.
Mancini, Francesca, Cristoforo Comi, Gaia Donata Oggioni, et al.. (2013). Prevalence and features of peripheral neuropathy in Parkinson's disease patients under different therapeutic regimens. Parkinsonism & Related Disorders. 20(1). 27–31. 70 indexed citations
11.
Maggioni, Martina Anna, A. Veicsteinas, Susanna Rampichini, et al.. (2011). Energy cost of spontaneous walking in Parkinson’s disease patients. Neurological Sciences. 33(4). 779–784. 19 indexed citations
12.
Frazzitta, Giuseppe, Gabriella Bertotti, Giulio Riboldazzi, et al.. (2011). Effectiveness of Intensive Inpatient Rehabilitation Treatment on Disease Progression in Parkinsonian Patients. Neurorehabilitation and neural repair. 26(2). 144–150. 96 indexed citations
13.
Guerini, Fabio, Ettore Beghi, Giulio Riboldazzi, et al.. (2009). BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson’s disease. European Journal of Neurology. 16(11). 1240–1245. 63 indexed citations
14.
Cosentino, Marco, E. Martignoni, Daniela Calandrella, et al.. (2005). Medical healthcare use in Parkinson's disease: survey in a cohort of ambulatory patients in Italy. BMC Health Services Research. 5(1). 26–26. 18 indexed citations
15.
Martignoni, E., L. Godi, A. Citterio, et al.. (2004). Comorbid disorders and hospitalisation in Parkinson?s disease: a prospective study. Neurological Sciences. 25(2). 66–71. 74 indexed citations
16.
Blandini, Fabio, Marco Cosentino, Franca Marino, et al.. (2004). Modifications of apoptosis-related protein levels in lymphocytes of patients with Parkinson?s disease. The effect of dopaminergic treatment. Journal of Neural Transmission. 111(8). 1017–30. 60 indexed citations
17.
Blandini, Fabio, Marco Cosentino, Franca Marino, et al.. (2003). Peripheral Markers of Apoptosis in Parkinson's Disease. Annals of the New York Academy of Sciences. 1010(1). 675–678. 31 indexed citations
18.
Martignoni, E., Giulio Riboldazzi, Daniela Calandrella, & Nilo Riva. (2003). Motor complications of Parkinson's disease. Neurological Sciences. 24(0). s27–s29. 10 indexed citations
19.
Blandini, Fabio, E. Martignoni, Alberta Samuele, et al.. (2003). Effects of dopaminergic stimulation on peripheral markers of apoptosis: relevance to Parkinson?s disease. Neurological Sciences. 24(3). 157–158. 8 indexed citations
20.
Martignoni, E., Rossella E. Nappi, A. Citterio, et al.. (2002). Parkinson's disease and reproductive life events. Neurological Sciences. 23(0). s85–s86. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026